View in EDS HTML Full Text PDF Full Text

Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma.

Saved in:
Bibliographic Details
Title: Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma.
Authors: Williamson, Julie1,2 (AUTHOR), Fadlullah, Muhammad Zaki Hidayatullah2 (AUTHOR), Kovacsovics-Bankowski, Magdalena2,3 (AUTHOR), Gibson, Berit2 (AUTHOR), Swami, Umang1,2 (AUTHOR), Erickson-Wayman, Alyssa2 (AUTHOR), Jamison, Debra2 (AUTHOR), Sageser, Dan2 (AUTHOR), Jeter, Joanne1,2 (AUTHOR), Bowles, Tawnya L.3 (AUTHOR), Cannon, Donald M.2 (AUTHOR), Haaland, Ben2 (AUTHOR), Schroeder, Joyce D.2 (AUTHOR), Nix, David A.2 (AUTHOR), Atkinson, Aaron2 (AUTHOR), Hyngstrom, John2 (AUTHOR), McPherson, Jordan2 (AUTHOR), Tan, Aik-Choon2 (AUTHOR), Hu-Lieskovan, Siwen1,2 (AUTHOR)
Source: Current Oncology. Mar2025, Vol. 32 Issue 3, p144. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11980052
DOI:10.3390/curroncol32030144